Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO

Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO

Head, Corneal Research Group, The University of Sydney, Save Sight Institute, Faculty of Medicine and Health; co-Deputy Director, Industry, Innovation and Commercialisation, Sydney Nano; Head, Corneal Unit, Sydney Eye Hospital; Chair, Australian Vision Research, Sydney, New South Wales, Australia

Professor Stephanie Watson OAM is a corneal surgeon known for her ground-breaking research in corneal therapies. She leads the Corneal Research Group at University of Sydney and is Head of the Corneal Unit at the Sydney Eye Hospital. For Sydney Nano she contributes to the executive leadership team as co-Deputy Director for Industry, Innovation and Commercialisation. As Chair, Australian Vision Research; recent past-Chair to the Association for Research in Vision and Ophthalmology's (ARVO) Advocacy and Outreach Committee Professor Watson has contributed to policy and advocacy. Her practice is in corneal and cataract surgery in adults and children with appointments at the Sydney Eye Hospital, Sydney Children's and Prince of Wales Hospitals where she is a RANZCO trainer. The Medal of the Order of Australia was awarded for services to ophthalmology. Professor Watson was the only Australian to make the Power List of the Top 100 women in Ophthalmology in 2021 and in 2022 and 2023 the only Australian woman on the Top 100 Global Power list for all ophthalmologists. In 2023, Professor Watson was awarded the Asia Pacific Eye 100: 100 Most influential Ophthalmologists and the Asia Pacific Academy of Ophthalmology Outstanding Service in Prevention of Blindness Award. She has received ARVO Silver Fellowship, New Zealand's Dorothy Potter Medal and an NSW Premier's Prize for Leadership in Innovation.

Disclosures

Dr. Watson has advised Novartis, Glakos and Sequirus, Alcon and Okogen

Recent Contributions to PracticeUpdate:

  1. Effect of Sodium Hyaluronate on Tear Film Stability in Patients With Dry Eye Syndrome After Cataract Surgery
  2. Outcomes of a Pulsed Therapy With Hydrocortisone Eye Drops for Moderate to Severe Dry Eye Disease in Patients With Primary Sjögren Syndrome
  3. Efficacy and Safety of a Water-Free Topical Cyclosporine 0.1% Solution for the Treatment of Moderate to Severe Dry Eye Disease
  4. Causes, Diagnosis, and Management of Scleral Thinning
  5. Association Between Serial Intravitreal Injections of Anti-VEGF and Dry Eye Parameters
  6. Prevalence of Ocular Demodex Folliculorum Infection and Associated Risk Factors in Young Males
  7. Corneal Complications Secondary to Involutional Entropion at Presentation
  8. 2022 Top Story in Eye Care: Can Caffeine Cause Dry Eye Disease?
  9. Visual Outcomes of Penetrating Keratoplasty in Patients With Open-Globe Injuries
  10. New Model to Better Diagnose Dry Eye Disease Integrating OCT Corneal Epithelial Mapping

Most Read This Week

Recently Updated